Mike & Patti Hennessy Foundation Champions Early Detection Research for Ovarian Cancer

Advancing Ovarian Cancer Research

The Mike & Patti Hennessy Foundation has made a significant contribution to cancer research by announcing a grant to the City of Hope, one of the leading cancer research and treatment institutions in the United States. This grant is pivotal for advancing the early detection of ovarian cancer, a disease that affects many women and is often diagnosed at an advanced stage.

The Importance of Early Detection

Ovarian cancer is notorious for its late diagnosis, which severely impacts survival rates. Statistically, when detected in the early stages, the survival rate exceeds 90%, but currently, only 20% of cases are diagnosed early enough. Traditional methods, including ultrasound and CA-125 blood tests, fail to provide the sensitivity necessary for early detection, leading to a pressing need for innovative screening techniques.

The grant provided by the Mike & Patti Hennessy Foundation is a part of its Ovarian Cancer Prevention and Early Detection Initiative, which signifies a multi-year investment in research that targets the underfunded area of ovarian cancer detection. This effort is crucial considering the lack of reliable tools to identify the disease at its inception.

Leading the Research

This initiative funds a research project led by Dr. Mihae Song and Dr. Patrick Pirrotte at City of Hope. Dr. Song, an assistant professor specializing in gynecologic oncology, and Dr. Pirrotte, who manages the Integrated Mass Spectrometry Shared Resource, are at the forefront of developing minimally invasive methods to detect ovarian cancer earlier. Their research aims to identify biological signals that indicate the presence of ovarian cancer, a pursuit that is crucial for improving the existing diagnostic landscape.

The funding from the Hennessy Foundation will not only allow for the expansion of this vital research but also help in validating new detection methods through rigorous testing. The ultimate goal is to transition these discoveries from the laboratory to clinical settings, ultimately allowing for routine usage.

A Collaborative Approach

In addition to support from the Hennessy Foundation, the City of Hope will partner with the Hackensack Meridian Hennessy Institute for Cancer Prevention and Applied Molecular Medicine. This collaboration is particularly noteworthy as it combines resources in New Jersey, aimed at translating research findings into practical clinical applications. Dr. Elias Obeid, the medical director of the Hennessy Institute, expressed optimism about this initiative, highlighting that it aligns with their mission to enhance cancer risk assessment and early detection.

“Today, there is still no reliable test to catch ovarian cancer at its earliest, when a diagnosis can make the biggest difference,” stated Shannon Pulaski on behalf of the Hennessy Foundation. This sentiment underscores the urgency of improving existing detection methods and fostering research that could lead to groundbreaking developments in how ovarian cancer is diagnosed.

Commitment to Change

The Mike & Patti Hennessy Foundation is dedicated to closing the funding gap present in ovarian cancer research. By supporting studies that explore new detection technologies, such as liquid biopsies and genomic risk models, the Foundation is actively contributing to a future where ovarian cancer can be diagnosed earlier and managed more effectively. The Foundation also welcomes proposals from other researchers seeking to innovate in the field of ovarian cancer prevention and early detection.

In conclusion, the partnership between the Mike & Patti Hennessy Foundation and City of Hope is a testament to the potential for collaborative efforts in combating ovarian cancer. With sustained investment and a focus on innovative research, there is hope for more accurate detection methods that could transform the clinical landscape and improve outcomes for women facing this challenging disease. For further information, the Foundation encourages interested parties to explore their website at mphennessyfoundation.com.